Scaling Psilocybin Therapy - New Podcast Episode From 'The Business Trip'

Uncategorised
Written By

This week, the excellent 'Business Trip Podcast' released a new episode, featuring Compass co-founder Lars Wilde.

Follow the link above to listen to Lars' take on psilocybin clinical trial design, how psilocybin therapy can be scaled to be most accessible, and the origin story of Compass Pathways: one of the giants in the psychedelic space (they are already entering Phase 3 trials for psilocybin therapy in Treatment Resistant Depression).

For more psychedelic news and research, visit the psychedelic health professional network homepage.

Previous

Sub-acute and long-term effects of ayahuasca on mental health and well-being in healthy ceremony attendants: A replication study
Next

Prescription Psychedelics: The Road from FDA Approval to Clinical Practice